Emcure Pharmaceuticals (EMCURE) — Corporate Action

📢 Key Event
AGM scheduled for September 21, 2026, to approve final dividend

🔄 What Changed
Final dividend of Rs. 3.60 per share recommended

🔮 What's Next
Payment within 30 days of AGM approval

💡 Investor Takeaway
Shareholders receive Rs. 3.60 per share dividend if approved at AGM.

Emcure Pharmaceuticals announced its 45th Annual General Meeting will be held on September 21, 2026, to approve a final dividend of Rs. 3.60 per share (36% yield) for FY2026, with the record date set for September 4, 2026, to determine shareholder eligibility.

📄 View Original Announcement (PDF)

📊 Stock Analysis — EMCURE ✨ Ask AI About This

About Emcure Pharmaceuticals Limited (EMCURE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹35,011.16 Cr P/E: 34.6 ROE: 22.9% ROCE: 29.7% Div Yield: 0.20%

View full EMCURE stock details →

📡 Get AI alerts when EMCURE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EMCURE — Free

💡 Ask AI about this filing

"When will the dividend be paid after AGM approval?" "What is the ex-dividend date for the final dividend?" "How does the 36% dividend yield compare to peers?"

Ask AI Free →

📊 More EMCURE filings

See all EMCURE filings →

🔥 Also filed on 6 August 2026

CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SUMEETINDS Sumeet Industries Limited Financial Results VISAKAIND Visaka Industries Limited Corporate Action VISAKAIND Visaka Industries Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results VSTL Vibhor Steel Tubes Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EMCURE files new disclosures

Track EMCURE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EMCURE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd